Matches in SemOpenAlex for { <https://semopenalex.org/work/W1969523085> ?p ?o ?g. }
- W1969523085 endingPage "261" @default.
- W1969523085 startingPage "251" @default.
- W1969523085 abstract "When contemplating a pregnancy, women treated for multiple sclerosis (MS) with a disease-modifying drug must decide to discontinue their medication before conception or risk exposing their unborn child to potential drug toxicity. Few studies exist as reference for patients and physicians, and of those available, the majority are less than ideal due to real-world constraints, ethical issues and methodological shortcomings. The authors provide a brief summary of existing animal and human data with current recommendations regarding the safety of IFN-β, glatiramer acetate, natalizumab, mitoxantrone, fingolimod and teriflunomide during pregnancy and lactation in women with MS. We also assess the quality, strengths and limitations of the existing studies including challenges with study design. The investigation of outcomes such as spontaneous abortion and congenital anomalies are highlighted with potential methodological improvements for future studies on drug safety in pregnancy suggested. The authors explore the pharmacokinetics and pharmacodynamics of the MS disease-modifying drugs for their possible mechanistic role in fetal harm and discuss the potential role of clinical trials. Future pharmacovigilance studies should continue to pursue multicenter collaboration with an emphasis on appropriate study design." @default.
- W1969523085 created "2016-06-24" @default.
- W1969523085 creator A5020892964 @default.
- W1969523085 creator A5025037775 @default.
- W1969523085 creator A5030980805 @default.
- W1969523085 creator A5048830057 @default.
- W1969523085 creator A5058070944 @default.
- W1969523085 creator A5078749346 @default.
- W1969523085 creator A5086335707 @default.
- W1969523085 creator A5089581744 @default.
- W1969523085 date "2013-03-01" @default.
- W1969523085 modified "2023-09-30" @default.
- W1969523085 title "Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance" @default.
- W1969523085 cites W1728764802 @default.
- W1969523085 cites W1840586683 @default.
- W1969523085 cites W1906643665 @default.
- W1969523085 cites W1938188185 @default.
- W1969523085 cites W1971547969 @default.
- W1969523085 cites W1972462606 @default.
- W1969523085 cites W1977406577 @default.
- W1969523085 cites W1977630796 @default.
- W1969523085 cites W1978827950 @default.
- W1969523085 cites W1982122736 @default.
- W1969523085 cites W1990257063 @default.
- W1969523085 cites W2023578804 @default.
- W1969523085 cites W2024451515 @default.
- W1969523085 cites W2026508776 @default.
- W1969523085 cites W2027504039 @default.
- W1969523085 cites W2033989229 @default.
- W1969523085 cites W2035234968 @default.
- W1969523085 cites W2035716757 @default.
- W1969523085 cites W2040969396 @default.
- W1969523085 cites W2044566162 @default.
- W1969523085 cites W2045750739 @default.
- W1969523085 cites W2046481589 @default.
- W1969523085 cites W2061642892 @default.
- W1969523085 cites W2062256859 @default.
- W1969523085 cites W2069379532 @default.
- W1969523085 cites W2074656146 @default.
- W1969523085 cites W2074924086 @default.
- W1969523085 cites W2075413744 @default.
- W1969523085 cites W2082007277 @default.
- W1969523085 cites W2084150146 @default.
- W1969523085 cites W2093075394 @default.
- W1969523085 cites W2098291431 @default.
- W1969523085 cites W2100170145 @default.
- W1969523085 cites W2112752702 @default.
- W1969523085 cites W2112875101 @default.
- W1969523085 cites W2113494903 @default.
- W1969523085 cites W2116526010 @default.
- W1969523085 cites W2122078487 @default.
- W1969523085 cites W2124016103 @default.
- W1969523085 cites W2124720965 @default.
- W1969523085 cites W2132894309 @default.
- W1969523085 cites W2140197659 @default.
- W1969523085 cites W2141292771 @default.
- W1969523085 cites W2146853951 @default.
- W1969523085 cites W2148877048 @default.
- W1969523085 cites W2151740555 @default.
- W1969523085 cites W2152684294 @default.
- W1969523085 cites W2157759118 @default.
- W1969523085 cites W2160313677 @default.
- W1969523085 cites W2167416335 @default.
- W1969523085 cites W2168309391 @default.
- W1969523085 cites W2168509534 @default.
- W1969523085 cites W2319459971 @default.
- W1969523085 cites W4211254511 @default.
- W1969523085 cites W4231236114 @default.
- W1969523085 cites W4237828627 @default.
- W1969523085 cites W4238734356 @default.
- W1969523085 doi "https://doi.org/10.1586/ern.13.12" @default.
- W1969523085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23448215" @default.
- W1969523085 hasPublicationYear "2013" @default.
- W1969523085 type Work @default.
- W1969523085 sameAs 1969523085 @default.
- W1969523085 citedByCount "29" @default.
- W1969523085 countsByYear W19695230852013 @default.
- W1969523085 countsByYear W19695230852014 @default.
- W1969523085 countsByYear W19695230852015 @default.
- W1969523085 countsByYear W19695230852016 @default.
- W1969523085 countsByYear W19695230852017 @default.
- W1969523085 countsByYear W19695230852018 @default.
- W1969523085 countsByYear W19695230852019 @default.
- W1969523085 countsByYear W19695230852020 @default.
- W1969523085 countsByYear W19695230852022 @default.
- W1969523085 countsByYear W19695230852023 @default.
- W1969523085 crossrefType "journal-article" @default.
- W1969523085 hasAuthorship W1969523085A5020892964 @default.
- W1969523085 hasAuthorship W1969523085A5025037775 @default.
- W1969523085 hasAuthorship W1969523085A5030980805 @default.
- W1969523085 hasAuthorship W1969523085A5048830057 @default.
- W1969523085 hasAuthorship W1969523085A5058070944 @default.
- W1969523085 hasAuthorship W1969523085A5078749346 @default.
- W1969523085 hasAuthorship W1969523085A5086335707 @default.
- W1969523085 hasAuthorship W1969523085A5089581744 @default.
- W1969523085 hasConcept C118552586 @default.
- W1969523085 hasConcept C126322002 @default.
- W1969523085 hasConcept C172680121 @default.